Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling minimal residual disease (MRD)-testing.

Anna Butturini1, John Klein, Robert Peter Gale

  • 1Department of Pediatrics, Division of Hematology Oncology, Childrens' Hospital Los Angeles, 4650 Sunset Blvd., Los Angeles, CA 90027-6016, USA. abutturini@chla.usc.edu

Leukemia Research
|January 18, 2003
PubMed
Summary

Accurate cancer minimal residual disease (MRD) detection requires more than just sensitive tests. Mathematical modeling shows that increasing sample size and frequency, along with a higher positive threshold, are crucial for reliable MRD testing results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting gene essentiality and drug response from preclinical perturbation screens with layered ensemble of autoencoders and predictors.

Scientific reports·2026
Same author

Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database.

BJUI compass·2026
Same author

First-in-US Pilot Study of Aquablation in Ambulatory Surgery Centers: Clinical Outcomes and Economic Feasibility.

Urology·2025
Same author

New Animated Training and Certification Application for NIHSS.

Stroke·2025
Same author

Combination Prostatic Artery Embolization Prior to Water-Jet Ablation (Aquablation) for Benign Prostatic Hypertrophy: A Propensity Score Analysis.

Journal of clinical medicine·2024
Same author

ASO Visual Abstract: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma Following Orthotopic Liver Transplantation.

Annals of surgical oncology·2024

Area of Science:

  • Oncology
  • Biostatistics
  • Medical Diagnostics

Background:

  • Minimal residual disease (MRD) detection is vital for cancer patient prognosis and treatment decisions.
  • Current efforts focus on developing highly sensitive methods for MRD testing in blood and bone marrow samples.

Purpose of the Study:

  • To mathematically model factors influencing the sensitivity and specificity of MRD testing.
  • To assess the impact of cancer cell prevalence, test characteristics, and sampling on MRD detection accuracy.

Main Methods:

  • Development of mathematical models to simulate MRD testing scenarios.
  • Comparison of model predictions with results from large-scale published studies.
  • Analysis of factors including cancer cell prevalence, test sensitivity/specificity, and sample size.

Related Experiment Videos

Main Results:

  • MRD test accuracy is significantly influenced by cancer cell prevalence, distribution, test parameters, and sample size.
  • At low cancer cell prevalences (≤10⁻⁴), MRD test results are often inaccurate.
  • Inadequate sampling is a primary limitation to MRD testing accuracy, even with highly sensitive tests.

Conclusions:

  • Increasing test sensitivity alone offers marginal benefits for MRD detection accuracy.
  • Enhanced sampling strategies (increased size and frequency) are essential for improving accuracy.
  • Implementing a higher positive threshold (e.g., ≥10⁻³) can significantly increase test specificity and reliability.